AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33402575 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Betamethasone Valerate 0.1% cream, applied twice daily during radiotherapy/chemo-radiotherapy
Number of subjects: 106
Study 33402575 — intervention group
Group type: COMPARATOR
Intervention: Control (arm B)
Number of subjects: 106
Study 32665218 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic ventral hernia repair (n=65)
Number of subjects: 124
Study 32665218 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic ventral hernia repair (n=59)
Number of subjects: 124
Study 35199419 — intervention group
Group type: EXPERIMENTAL
Intervention: Value-based counselling (VBC)
Number of subjects: 103
Study 35199419 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 103
Study 32543287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical predictive scoring system established from model group analysis.
Number of subjects: 236
Study 32543287 — intervention group
Group type: COMPARATOR
Intervention: Model group analysis (incision-infection group vs non-infection group).
Number of subjects: 236
Study 35550854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 190
Study 35550854 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 190
Study 33902072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin, gentamicin, and metronidazole (group 1)
Number of subjects: 180
Study 33902072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin, gentamicin, and clindamycin (group 2)
Number of subjects: 180
Study 33902072 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin‐tazobactam and gentamicin (group 3)
Number of subjects: 180
Study 33902072 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 180
Study 35089205 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic cement coating group
Number of subjects: 36
Study 35089205 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 33832490 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of periodontal curettage and root planing
Number of subjects: 72
Study 33832490 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 72
Study 33832490 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal curettage
Number of subjects: 72
Study 33832490 — intervention group
Group type: COMPARATOR
Intervention: Cleansing
Number of subjects: 72
Study 33686187 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature-born adults
Number of subjects: 101
Study 33686187 — intervention group
Group type: COMPARATOR
Intervention: Full-term controls
Number of subjects: 101
Study 33032164 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) intervention
Number of subjects: 180
Study 33032164 — intervention group
Group type: COMPARATOR
Intervention: Control (biomass cooking)
Number of subjects: 180
Study 35172071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive Surgery
Number of subjects: 0
Study 35172071 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33054737 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema therapy
Number of subjects: 300
Study 33054737 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy
Number of subjects: 300
Study 33054737 — intervention group
Group type: COMPARATOR
Intervention: Individual supportive therapy
Number of subjects: 300
Study 34257352 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 1056
Study 34257352 — intervention group
Group type: COMPARATOR
Intervention: Control group (randomly assigned)
Number of subjects: 1056
Study 34257352 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2 Ile655Val polymorphism
Number of subjects: 1056
Study 34257352 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient characteristics
Number of subjects: 1056
Study 33070366 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC/MMF
Number of subjects: 150
Study 33070366 — intervention group
Group type: COMPARATOR
Intervention: TAC/SRL
Number of subjects: 150
Study 33070366 — intervention group
Group type: COMPARATOR
Intervention: CSA/SRL
Number of subjects: 150
Study 33070366 — intervention group
Group type: COMPARATOR
Intervention: TAC/SRL and CSA/SRL
Number of subjects: 150
Study 35385050 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab (50, 150, and 300 mg once every 3 months)
Number of subjects: 338
Study 35385050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study 32453275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronine‐alanine‐valine homozygous haplotype
Number of subjects: 42
Study 32453275 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype
Number of subjects: 42
Study 33011715 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (n = 46) - four-week online intervention promoting analytical thinking through the Gamblers Fallacy Questionnaire
Number of subjects: 94
Study 33011715 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 48)
Number of subjects: 94
Study 35954937 — intervention group
Group type: EXPERIMENTAL
Intervention: Seawater hydration (Totum SPORT, Laboratories Quinton International, S.L., Valencia, Spain)
Number of subjects: 15
Study 35954937 — intervention group
Group type: COMPARATOR
Intervention: Tap water (ad libitum)
Number of subjects: 15
Study 35954937 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline solution (placebo)
Number of subjects: 15
Study 33533155 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% agarose gel
Number of subjects: 66
Study 33533155 — intervention group
Group type: COMPARATOR
Intervention: NASHA-L
Number of subjects: 66
Study 33533155 — intervention group
Group type: COMPARATOR
Intervention: 2.5% agarose gel and NASHA-L
Number of subjects: 66
Study 32853585 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab group (brentuximab vedotin 1.8 mg/kg with ipilimumab 1 mg/kg or 3 mg/kg)
Number of subjects: 61
Study 32853585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab group (brentuximab vedotin 1.2 mg/kg or 1.8 mg/kg with nivolumab 3 mg/kg)
Number of subjects: 61
Study 32853585 — intervention group
Group type: EXPERIMENTAL
Intervention: Triplet therapy group (brentuximab vedotin 1.2 mg/kg or 1.8 mg/kg with nivolumab 3 mg/kg and ipilimumab 1 mg/kg)
Number of subjects: 61
Study 34112001 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurolock‐hep500™ as a catheter lock solution
Number of subjects: 60
Study 34112001 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin as a catheter lock solution
Number of subjects: 60
Study 34656191 — intervention group
Group type: EXPERIMENTAL
Intervention: SET‐C (Social Effectiveness Therapy for Children)
Number of subjects: 63
Study 34656191 — intervention group
Group type: COMPARATOR
Intervention: Pegasys‐VR™
Number of subjects: 63
Study 32256897 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication review service (delivered by clinical pharmacists)
Number of subjects: 106
Study 32256897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication review service)
Number of subjects: 106
Study 32256897 — intervention group
Group type: EXPERIMENTAL
Intervention: All refugee patients (both groups)
Number of subjects: 106
Study 34092002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided quadratus lumborum block combined with general anaesthesia
Number of subjects: 76
Study 32075675 — intervention group
Group type: EXPERIMENTAL
Intervention: START initiative
Number of subjects: 61
Study 34505555 — intervention group
Group type: EXPERIMENTAL
Intervention: Online adaptive attention training (SAT) for 4 weeks
Number of subjects: 80
Study 34505555 — intervention group
Group type: COMPARATOR
Intervention: Working memory training (WMT) for 4 weeks
Number of subjects: 80
Study 34505555 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL) for 4 weeks
Number of subjects: 80
Study 34289820 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed formula (EHF) at 2.4 g protein/100 kcal
Number of subjects: 0
Study 34289820 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid-based formula (AAF) at 2.4 g total protein equivalents/100 kcal
Number of subjects: 0
Study 34289820 — intervention group
Group type: COMPARATOR
Intervention: Control group (EH casein formula at 2.8 g protein/100 kcal)
Number of subjects: 0
Study 34528408 — intervention group
Group type: EXPERIMENTAL
Intervention: Repository corticotropin injection (RCI; 80 IU subcutaneously twice weekly on study days 1 and 4)
Number of subjects: 48
Study 34528408 — intervention group
Group type: COMPARATOR
Intervention: Synthetic ACTH1-24 depot (1 mg subcutaneously twice weekly on study days 1 and 4)
Number of subjects: 48
Study 34528408 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (32 mg orally once daily on study days 1 through 6)
Number of subjects: 48
Study 35186225 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality nursing intervention based on humanistic care combined with the project teaching method (EG)
Number of subjects: 114
Study 35186225 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing during chemotherapy (CG)
Number of subjects: 114
Study 35044988 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree model
Number of subjects: 710
Study 35044988 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 710
Study 33507984 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual caries preventive intervention including placement of fissure sealants, application of povidone-iodine and fluoride varnish, and standard diet and oral hygiene advice.
Number of subjects: 408
Study 33507984 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 408
Study 36036106 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal acupuncture
Number of subjects: 80
Study 36036106 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 80
Study 32677847 — intervention group
Group type: COMPARATOR
Intervention: TCONS_00483150
Number of subjects: 0
Study 35604760 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-Care Visit (WCV)
Number of subjects: 217
Study 35604760 — intervention group
Group type: EXPERIMENTAL
Intervention: WCV with CBT app
Number of subjects: 217
Study 35604760 — intervention group
Group type: COMPARATOR
Intervention: WCV
Number of subjects: 217
Study 35604760 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT app
Number of subjects: 217
Study 33237903 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network algorithm for skin cancer detection (AUC 0.863) using unprocessed clinical photographs.
Number of subjects: 10426
Study 33237903 — intervention group
Group type: COMPARATOR
Intervention: First clinical impression of 65 attending physicians.
Number of subjects: 10426
Study 33237903 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network algorithm for batches of 30 patients.
Number of subjects: 10426
Study 33237903 — intervention group
Group type: COMPARATOR
Intervention: First impression of 44 dermatologists in reader test.
Number of subjects: 10426
Study 35351124 — intervention group
Group type: EXPERIMENTAL
Intervention: TIME intervention
Number of subjects: 40
Study 35351124 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 40
Study 34089578 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 885
Study 34089578 — intervention group
Group type: COMPARATOR
Intervention: Medical Therapy
Number of subjects: 885
Study 33139757 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Bifidobacterium-animalis-subsp.-Lactis 10×10^9 and Lactobacillus-Acidophilus 10×10^9 + 5 g of maltodextrin)
Number of subjects: 27
Study 33139757 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 g of maltodextrin)
Number of subjects: 27
Study 33139757 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 27
Study 34425251 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-lb weighted blanket
Number of subjects: 94
Study 34425251 — intervention group
Group type: COMPARATOR
Intervention: 5-lb weighted blanket
Number of subjects: 94
Study 32185522 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta distribution-based approach
Number of subjects: 0
Study 32185522 — intervention group
Group type: COMPARATOR
Intervention: Standard continuous analysis approach
Number of subjects: 0
Study 33952318 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU-specific virtual reality (ICU-VR) intervention offered 3 months after hospital discharge
Number of subjects: 80
Study 33952318 — intervention group
Group type: COMPARATOR
Intervention: ICU-specific virtual reality (ICU-VR) intervention offered 6 months after hospital discharge (late ICU-VR)
Number of subjects: 80
Study 32541620 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Work (DW) Intervention
Number of subjects: 244
Study 32541620 — intervention group
Group type: COMPARATOR
Intervention: Usual Practice (Control)
Number of subjects: 244
Study 33478302 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group with diversified and quantitative exercise intervention management mode (at least 30 min per day, not less than 150 min per week)
Number of subjects: 138
Study 33478302 — intervention group
Group type: COMPARATOR
Intervention: Control group with conventional sports
Number of subjects: 138
Study 33662491 — intervention group
Group type: EXPERIMENTAL
Intervention: D-CLIP intervention
Number of subjects: 573
Study 35776441 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV and STI testing
Number of subjects: 414
Study 35776441 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV testing
Number of subjects: 414
Study 35776441 — intervention group
Group type: EXPERIMENTAL
Intervention: STI testing
Number of subjects: 414
Study 34133831 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal nerve block (RIB)
Number of subjects: 90
Study 34133831 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 90
Study 34133831 — intervention group
Group type: COMPARATOR
Intervention: Serratus plane block (SAB)
Number of subjects: 90
Study 32413540 — intervention group
Group type: COMPARATOR
Intervention: Paired-pulse Transcranial Magnetic Stimulation (ppTMS) delivered at 120% resting motor threshold (RMT) at two locations: 3 cm dorsal and 5 cm lateral to inion, or at the site of peak activation for motion according to NeuroSynth fMRI database.
Number of subjects: 15
Study 35979845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologically relevant neuropsychological battery (Six Elements, Zoo Map, Hayling Sentence Completion, Iowa Gambling, Auditory Startle Tasks)
Number of subjects: 59
Study 35979845 — intervention group
Group type: COMPARATOR
Intervention: Traditional EF tasks (Card Sorting, Trail Making, Color-Word Interference, Verbal Fluency)
Number of subjects: 59
Study 33830025 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus and Mycophenolate Mofetil (MMF) for GVHD prophylaxis
Number of subjects: 150
Study 32649856 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin-induced platelet aggregation
Number of subjects: 0
Study 32649856 — intervention group
Group type: EXPERIMENTAL
Intervention: GRK5 variant (rs10886430-G)
Number of subjects: 0
Study 32649856 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 0
Study 32649856 — intervention group
Group type: EXPERIMENTAL
Intervention: G protein-coupled receptor kinase 5 (GRK5)
Number of subjects: 0
Study 35427476 — intervention group
Group type: EXPERIMENTAL
Intervention: DC371739
Number of subjects: 0
Study 35427476 — intervention group
Group type: EXPERIMENTAL
Intervention: DC371739 + Atorvastatin
Number of subjects: 0
Study 32709507 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 4 drops of 2% lavender essential oil with oxygen for 20 minutes
Number of subjects: 90
Study 32709507 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of oxygen only
Number of subjects: 90
Study 35042472 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic asthma
Number of subjects: 1506
Study 35042472 — intervention group
Group type: COMPARATOR
Intervention: Non-allergic asthma
Number of subjects: 1506
Study 35042472 — intervention group
Group type: COMPARATOR
Intervention: Inhalative allergy
Number of subjects: 1506
Study 34508693 — intervention group
Group type: EXPERIMENTAL
Intervention: Losmapimod
Number of subjects: 3489
Study 34508693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3489
Study 33067319 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg oral two times per day) plus avelumab (10 mg/kg intravenous every 2 weeks) in Cohort-1
Number of subjects: 54
Study 33067319 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib monotherapy in Cohort-2 (avelumab added after 6 weeks if corticosteroid dose could be tapered to ≤8 mg)
Number of subjects: 54
Study 35394525 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive STEPS intervention (community health worker-led, 7-week duration, weekly telephone sessions, web-based videos, positive activities, wearable activity trackers)
Number of subjects: 46
Study 35394525 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive STEPS intervention
Number of subjects: 46
Study 33760027 — intervention group
Group type: EXPERIMENTAL
Intervention: edoxaban (oral factor Xa inhibitor)
Number of subjects: 6308
Study 32792320 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (n = 40)
Number of subjects: 60
Study 32792320 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study 36357636 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal muscle ultrasound assessment (QRFT and QVIT)
Number of subjects: 40
Study 36357636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake assessment
Number of subjects: 40
Study 36357636 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal muscle ultrasound assessment (QRFT)
Number of subjects: 40
Study 33906695 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal gun
Number of subjects: 76
Study 33906695 — intervention group
Group type: COMPARATOR
Intervention: Heat pack
Number of subjects: 76
Study 37244809 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of PCV20 and BNT162b2
Number of subjects: 570
Study 37244809 — intervention group
Group type: COMPARATOR
Intervention: PCV20 only
Number of subjects: 570
Study 37244809 — intervention group
Group type: COMPARATOR
Intervention: BNT162b2 only
Number of subjects: 570
Study 34197133 — intervention group
Group type: EXPERIMENTAL
Intervention: Go/No-Go training (HitnRun)
Number of subjects: 106
Study 34197133 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational brochure (Control)
Number of subjects: 106
Study 32311555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH) for 14 days in patients older than 70 years
Number of subjects: 19
Study 32311555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH) in patients younger than 70 years
Number of subjects: 19
Study 32311555 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin and danaparoid
Number of subjects: 19
Study 32311555 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19
Study 35961517 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose autologous skeletal muscle-derived cells
Number of subjects: 0
Study 35961517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose autologous skeletal muscle-derived cells
Number of subjects: 0
Study 33468112 — intervention group
Group type: EXPERIMENTAL
Intervention: National salt iodization program
Number of subjects: 408
Study 32408245 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-phase video-assisted debriefing (VAD)
Number of subjects: 145
Study 32408245 — intervention group
Group type: COMPARATOR
Intervention: Verbal debriefing (VD)
Number of subjects: 145
Study 35930287 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 400
Study 35930287 — intervention group
Group type: COMPARATOR
Intervention: NRT
Number of subjects: 400
Study 35930287 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytisine
Number of subjects: 400
Study 35930287 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior change (post hoc analysis)
Number of subjects: 400
Study 32171637 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids intervention (specific dosage and duration not mentioned)
Number of subjects: 207
Study 35261299 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone (DRSP) 4 mg
Number of subjects: 249
Study 35261299 — intervention group
Group type: COMPARATOR
Intervention: Desogestrel (DSG) 0.075 mg
Number of subjects: 249
Study 33407051 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion (WI) - 30 minutes standing immobile in a swimming pool
Number of subjects: 14
Study 33407051 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion (WI) - 30 minutes walking in the pool
Number of subjects: 14
Study 33407051 — intervention group
Group type: COMPARATOR
Intervention: Walking on ground - 30 minutes
Number of subjects: 14
Study 33253306 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 54
Study 33253306 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anesthesia (SA)
Number of subjects: 54
Study 33253306 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 54
Study 34269455 — intervention group
Group type: EXPERIMENTAL
Intervention: 450-ml blood donation
Number of subjects: 14
Study 34269455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no blood donation)
Number of subjects: 14
Study 36418502 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental desensitizing gel (10% calcium gluconate, 0.1% dexamethasone acetate, 10% potassium nitrate, 5% glutaraldehyde) applied for 10 min before bleaching.
Number of subjects: 50
Study 36418502 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel applied for 10 min before bleaching.
Number of subjects: 50
Study 36418502 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups underwent in-office bleaching with 35% hydrogen peroxide for 50 min, two sessions, 1-week interval.
Number of subjects: 50
Study 34189760 — intervention group
Group type: EXPERIMENTAL
Intervention: 55% of 1RM (MSR group)
Number of subjects: 44